Clinical Trial Update: Omega-3 Fatty Acids to Combat Sarcopenia [Phase 1]

View source ↗

Summary

A Phase 1 trial sponsored by Mayo Clinic evaluated omega-3 fatty acids for the treatment of sarcopenia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcopenia

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Mayo Clinic | Conditions: Sarcopenia | Phase 1 | Status: COMPLETED